Von Willebrand disease and aging: An evolving phenotype

Journal of Thrombosis and Haemostasis

Volumn 12, Issue 7, 2014, Pages 1066-1075

  Sanders, Y V ^a   Giezenaar, M A ^a   Laros van Gorkom, B A P ^b   Meijer, K ^c   van der Bom, J G ^d,e   Cnossen, M H ^a,f   Nijziel, M R ^g   Ypma, P F ^h   Fijnvandraat, K ^i,k   Eikenboom, J ^d   Mauser Bunschoten, E P ^j   Leebeek, F W G ^a   Middeldorp, S ^k   Kors, A ^l   Zweegman, S ^l   de Meris, J ^m   Jonkers, M H ⁿ   Dors, N ^o   Tamminga, R Y J ^c   van der Linden, P W ^p   Smiers, F J W ^d   Granzen, B ^q   Hamulyak, K ^q   Brons, P ^b   more..

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e SANQUIN RESEARCH   (Netherlands)

^f SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^g MÁXIMA MEDICAL CENTER   (Netherlands)

^h HAGA HOSPITAL   (Netherlands)

ⁱ EMMA CHILDREN S HOSPITAL   (Netherlands)

^j UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^k ACADEMIC MEDICAL CENTER   (Netherlands)

^l VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^m Netherlands Hemophilia Society   (Netherlands)

ⁿ AMPHIA HOSPITAL   (Netherlands)

^o CATHARINA HOSPITAL   (Netherlands)

^p N   (Netherlands)

^q MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

Aging; Factor VIII; Hemorrhage; Von Willebrand disease; Von Willebrand factor

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR CONCENTRATE; DESMOPRESSIN; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; BLEEDING; BLOOD GROUP O; BRAIN HEMORRHAGE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; INTRAOCULAR HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORBIDITY; MUSCLE HEMATOMA; PHENOTYPE; PILOT STUDY; POSTOPERATIVE HEMORRHAGE; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; TOOTH EXTRACTION; VON WILLEBRAND DISEASE; AGE; HOSPITALIZATION; METABOLISM; MIDDLE AGED; NETHERLANDS; PATHOPHYSIOLOGY; VERY ELDERLY; VON WILLEBRAND DISEASES; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; CROSS-SECTIONAL STUDIES; FEMALE; HEMORRHAGE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PHENOTYPE; VON WILLEBRAND DISEASES; VON WILLEBRAND FACTOR; YOUNG ADULT;

EID: 84904249971     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12586     Document Type: Article

References (40)

1. James PD, Lillicrap D. von Willebrand disease: clinical and laboratory lessons learned from the large von Willebrand disease studies. Am J Hematol 2012; 87(Suppl. 1): S4-11.
2. Ruggeri ZM. Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation. Best Pract Res Clin Haematol 2001; 14: 257-79.
3. De Wee EM, Sanders YV, Mauser-Bunschoten EP, van der Bom JG, Degenaar-Dujardin ME, Eikenboom J, De Goede-Bolder A, Laros-van Gorkom BA, Meijer K, Hamulyak K, Nijziel MR, Fijnvandraat K, Leebeek FW, for the WiN study group. Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease. Thromb Haemost 2012; 108: 683-92.
4. Tosetto A, Rodeghiero F, Castaman G, Goodeve A, Federici AB, Batlle J, Meyer D, Fressinaud E, Mazurier C, Goudemand J, Eikenboom J, Schneppenheim R, Budde U, Ingerslev J, Vorlova Z, Habart D, Holmberg L, Lethagen S, Pasi J, Hill F, et al. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost 2006; 4: 766-73.
5. Sadler JE, Mannucci PM, Berntorp E, Bochkov N, Boulyjenkov V, Ginsburg D, Meyer D, Peake I, Rodeghiero F, Srivastava A. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost 2000; 84: 160-74.
6. Sadler JE, Budde U, Eikenboom JC, Favaloro EJ, Hill FG, Holmberg L, Ingerslev J, Lee CA, Lillicrap D, Mannucci PM, Mazurier C, Meyer D, Nichols WL, Nishino M, Peake IR, Rodeghiero F, Schneppenheim R, Ruggeri ZM, Srivastava A, Montgomery RR, et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost 2006; 4: 2103-14.
7. Miesbach W, Berntorp E. When von Willebrand disease comes into age - a matter of change? Eur J Haematol 2011; 86: 496-501.
8. Vischer UM, Herrmann FR, Peyrard T, Nzietchueng R, Benetos A. Plasma von Willebrand factor and arterial aging. J Thromb Haemost 2005; 3: 794-5.
9. Mari D, Coppola R, Provenzano R. Hemostasis factors and aging. Exp Gerontol 2008; 43: 66-73.
10. van Loon JE, Kavousi M, Leebeek FW, Felix JF, Hofman A, Witteman JC, de Maat MP. von willebrand factor plasma levels, genetic variations, and coronary heart disease in an older population. J Thromb Haemost 2012; 10: 1262-9.
11. Mauser-Bunschoten EP, Fransen Van De Putte DE, Schutgens RE. Co-morbidity in the ageing haemophilia patient: the down side of increased life expectancy. Haemophilia 2009; 15: 853-63.
12. Sanders YV, Eikenboom J, de Wee EM, van der Bom JG, Cnossen MH, Degenaar-Dujardin ME, Fijnvandraat K, Kamphuisen PW, van Gorkom BA, Meijer K, Mauser-Bunschoten EP, Leebeek FW, for the WiN study group. Reduced prevalence of arterial thrombosis in von Willebrand disease. J Thromb Haemost 2013; 11: 845-54.
13. de Wee EM, Leebeek FW, Eikenboom JC. Diagnosis and management of von Willebrand disease in The Netherlands. Semin Thromb Hemost 2011; 37: 480-7.
14. de Wee EM, Mauser-Bunschoten EP, van der Bom JG, Degenaar-Dujardin ME, Eikenboom HCJ, Fijnvandraat K, de Goede-Bolder A, Laros-van Gorkom BAP, Meijer K, Raat H, Leebeek FWG, for the WiN study group. Health-related quality of life among adult patients with moderate and severe von Willebrand disease. J Thromb Haemost 2010; 8: 1492-9.
15. De Wee EM, Knol HM, Mauser-Bunschoten EP, van der Bom JG, Eikenboom JC, Fijnvandraat K, De Goede-Bolder A, Laros-van Gorkom B, Ypma PF, Zweegman S, Meijer K, Leebeek FW. Gynaecological and obstetric bleeding in moderate and severe von Willebrand disease. Thromb Haemost 2011; 106: 885-92.
16. Boren MT, Ramey J. Thinking aloud: reconciling theory and practice. IEEE Trans Prof Commun 2000; 43: 261-78.
17. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217-23.
18. Tosetto A, Castaman G, Rodeghiero F. Bleeding scores in inherited bleeding disorders: clinical or research tools? Haemophilia 2008; 14: 415-22.
19. World Health Organization. Definition of An Older or Elderly Person. Geneva, Switzerland: WHO, 2001.
20. Rodeghiero F, Tosetto A, Abshire T, Arnold DM, Coller B, James P, Neunert C, Lillicrap D, VWF ISj, Perinatal/Pediatric Hemostasis Subcommittees Working G. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost 2010; 8: 2063-5.
21. Conlan MG, Folsom AR, Finch A, Davis CE, Sorlie P, Marcucci G, Wu KK. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 1993; 70: 380-5.
22. Rydz N, Grabell J, Lillicrap D, P J. Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease. Haemophilia 2012; 18: PO-MO-249.
23. Castaman G, Federici AB, Tosetto A, La Marca S, Stufano F, Mannucci PM, Rodeghiero F. Different bleeding risk in type 2A and 2M von Willebrand disease: a 2-year prospective study in 107 patients. J Thromb Haemost 2012; 10: 632-8.
24. Sharma R, Gorbien MJ. Angiodysplasia and lower gastrointestinal tract bleeding in elderly patients. Arch Intern Med 1995; 155: 807-12.
25. Makris M. Gastrointestinal bleeding in von Willebrand disease. Thromb Res 2006; 118(Suppl. 1): S13-7.
26. Cooper BT, Weston CF, Neumann CS. Acute upper gastrointestinal haemorrhage in patients aged 80 years or more. Q J Med 1988; 68: 765-74.
27. Longstreth GF. Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population-based study. Am J Gastroenterol 1995; 90: 206-10.
28. Federici AB. Prophylaxis of bleeding episodes in patients with von Willebrand's disease. Blood Transfus 2008; 6(Suppl. 2): s26-32.
29. Abshire TC, Federici AB, Alvarez MT, Bowen J, Carcao MD, Cox GillJ, Key NS, Kouides PA, Kurnik K, Lail AE, Leebeek FW, Makris M, Mannucci PM, Winikoff R, Berntorp E, Vwd PN. Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN). Haemophilia 2013; 19: 76-81.
30. Siboni SM, Mannucci PM, Gringeri A, Franchini M, Tagliaferri A, Ferretti M, Tradati FC, Santagostino E, von Mackensen S. Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy. J Thromb Haemost 2009; 7: 780-6.
31. Franchini M, Mannucci PM. Co-morbidities and quality of life in elderly persons with haemophilia. Br J Haematol 2010; 148: 522-33.
32. Kistler U, Kramers-de Quervain I, Munzinger U, Kucher N. Bleeding complications after systematic switch of routine thromboprophylaxis for major orthopaedic surgery. Thromb Haemost 2008; 99: 1049-52.
33. Gommer AM, Poos MJJC. Prevalence, incidence and mortality according to age and gender. In: Volksgezondheid VTVNK, ed. Bilthoven: RIVM, 2010. http://www.nationaalkompas.nl. (Accessed 22 September 2011).
34. Fransen van de Putte DE, Fischer K, Pulles AE, Roosendaal G, Biesma DH, Schutgens RE, Mauser-Bunschoten EP. Non-fatal cardiovascular disease, malignancies, and other co-morbidity in adult haemophilia patients. Thromb Res 2012; 130: 157-62.
35. Mannucci PM, Schutgens RE, Santagostino E, Mauser-Bunschoten EP. How I treat age-related morbidities in elderly persons with hemophilia. Blood 2009; 114: 5256-63.
36. Fransen van de Putte DE, Makris M, Fischer K, Yee TT, Kirk L, Erpecum KJ, Patch D, Posthouwer D, Mauser-Bunschoten EP. Long-term follow-up of hepatitis C infection in a large cohort of patients with inherited bleeding disorders. J Hepatol 2014; 60: 39-45.
37. Federici AB, Santagostino E, Rumi MG, Russo A, Mancuso ME, Soffredini R, Mannucci PM, Colombo M. The natural history of hepatitis C virus infection in Italian patients with von Willebrand's disease: a cohort study. Haematologica 2006; 91: 503-8.
38. Dutch Cancer Registry. the Netherlands: IKNL, 2014. http://www.cijfersoverkanker.nl (Accessed 21 January 2014).
39. Franchini M, Lippi G, Montagnana M, Targher G, Zaffanello M, Salvagno GL, Rivolta GF, Perna CD, Tagliaferri A. Hemophilia and cancer: a new challenge for hemophilia centers. Cancer Treat Rev 2009; 35: 374-7.
40. Franchini M, Coppola A. Atherothrombosis in von Willebrand disease: an analysis of the literature and implications for clinical management. Semin Thromb Hemost 2012; 38: 185-99.